Skip to main content

Intrathecal Baclofen Therapy

  • Chapter
  • First Online:
Spasticity and Muscle Stiffness
  • 628 Accesses

Abstract

Intrathecal baclofen (ITB) exerts its therapeutic effect by delivering baclofen directly into the cerebrospinal fluid with rapid distribution to GABA-B-rich neurons in lamina II of the spinal cord. It is indicated for poorly-controlled, generalized spasticity despite maximal therapy and/or limited tolerance of other treatment modalities in patients with spasticity of spinal (traumatic spinal cord injury and multiple sclerosis) and cerebral (acquired brain injury, cerebral palsy, and stroke) origin. ITB therapy is accomplished through the use of a surgically-implanted, programmable pump that delivers drug at precise flow rates via a catheter introduced into the spinal canal. This chapter reviews the components of ITB therapy, patient selection, trial dose, pump implantation and ITB therapy initiation, pump maintenance and chronic therapy, troubleshooting, management of ITB overdose and withdrawal, and pump explantation. Successful implementation of ITB therapy requires a robust team structure to manage the routine, urgent, and emergent needs of the patients receiving this treatment.

Medicine is a science of uncertainty and an art of probability.

– William Osler, The Principles and Practices of Medicine, 1892.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Meng E, Hoang T. MEMS-enabled implantable drug infusion pumps for laboratory animal research, preclinical, and clinical applications. Adv Drug Deliv Rev. 2012;64(14):1628–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Pope JE. Intrathecal drug delivery: available technologies. In: Pope JE, Deer TR, editors. Treatment of chronic pain conditions: a comprehensive handbook. New York: Springer New York; 2017. p. 191–3.

    Chapter  Google Scholar 

  3. Ethans KD, Schryvers OI, Nance PW, Casey AR. Intrathecal drug therapy using the Codman Model 3000 constant flow implantable infusion pumps: experience with 17 cases. Spinal Cord. 2005;43(4):214–8.

    Article  CAS  PubMed  Google Scholar 

  4. Czernicki M, Sinovich G, Mihaylov I, Nejad B, Kunnumpurath S, Kodumudi G, et al. Intrathecal drug delivery for chronic pain management-scope, limitations and future. J Clin Monit Comput. 2015;29(2):241–9.

    Article  CAS  PubMed  Google Scholar 

  5. Saulino M, Turner M, Miesel K, Cochran FR, Stromberg K, Fehrmann E, et al. Can cerebrospinal fluid pressure detect catheter complications in patients who experience loss of effectiveness with intrathecal baclofen therapy? Neuromodulation. 2017;20(2):187–97.

    Article  PubMed  Google Scholar 

  6. Saulino M, Ivanhoe CB, McGuire JR, Ridley B, Shilt JS, Boster AL. Best practices for intrathecal baclofen therapy: patient selection. Neuromodulation. 2016;19(6):607–15.

    Article  PubMed  Google Scholar 

  7. Francisco GE, Yablon SA, Schiess MC, Wiggs L, Cavalier S, Grissom S. Consensus panel guidelines for the use of intrathecal baclofen therapy in poststroke spastic hypertonia. Top Stroke Rehabil. 2006;13(4):74–85.

    Article  PubMed  Google Scholar 

  8. Sadiq SA, Wang GC. Long-term intrathecal baclofen therapy in ambulatory patients with spasticity. J Neurol. 2006;253(5):563–9.

    Article  CAS  PubMed  Google Scholar 

  9. Francisco GE. The role of intrathecal baclofen therapy in the upper motor neuron syndrome. Eura Medicophys. 2004;40(2):131–43.

    CAS  PubMed  Google Scholar 

  10. Francisco GE, Hu MM, Boake C, Ivanhoe CB. Efficacy of early use of intrathecal baclofen therapy for treating spastic hypertonia due to acquired brain injury. Brain Inj. 2005;19(5):359–64.

    Article  CAS  PubMed  Google Scholar 

  11. Burns AS, Meythaler JM. Intrathecal baclofen in tetraplegia of spinal origin: efficacy for upper extremity hypertonia. Spinal Cord. 2001;39(8):413–9.

    Article  CAS  PubMed  Google Scholar 

  12. Sivakumar G, Yap Y, Tsegaye M, Vloeberghs M. Intrathecal baclofen therapy for spasticity of cerebral origin-does the position of the intrathecal catheter matter? Childs Nerv Syst. 2010;26(8):1097–102.

    Article  PubMed  Google Scholar 

  13. Fulkerson DH, Boaz JC, Luerssen TG. Interaction of ventriculoperitoneal shunt and baclofen pump. Childs Nerv Syst. 2007;23(7):733–8.

    Article  PubMed  Google Scholar 

  14. Buonaguro V, Scelsa B, Curci D, Monforte S, Iuorno T, Motta F. Epilepsy and intrathecal baclofen therapy in children with cerebral palsy. Pediatr Neurol. 2005;33(2):110–3.

    Article  PubMed  Google Scholar 

  15. Schuele SU, Kellinghaus C, Shook SJ, Boulis N, Bethoux FA, Loddenkemper T. Incidence of seizures in patients with multiple sclerosis treated with intrathecal baclofen. Neurology. 2005;64(6):1086–7.

    Article  CAS  PubMed  Google Scholar 

  16. Solaro C. Incidence of seizures in patients with multiple sclerosis treated with intrathecal baclofen. Neurology. 2006;66(5):784–5; author reply 784–5.

    Article  PubMed  Google Scholar 

  17. Toh Yoon EW, Kobayashi M. Percutaneous endoscopic gastrostomy in a patient with continuous intrathecal baclofen infusion therapy. Gastroenterology Res. 2017;10(2):132–4.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Martens FM, Somford DM, van Kuppevelt DH, van den Burg MJ, Heesakkers JP. Retraction of an intrathecal baclofen infusion catheter following suprapubic cystotomy: a case report. J Rehabil Med. 2009;41(1):90–1.

    Article  PubMed  Google Scholar 

  19. Stempien L, Tsai T. Intrathecal baclofen pump use for spasticity: a clinical survey. Am J Phys Med Rehabil. 2000;79(6):536–41.

    Article  CAS  PubMed  Google Scholar 

  20. Hoving MA, van Raak EP, Spincemaille GH, Palmans LJ, Sleypen FA, Vles JS, et al. Intrathecal baclofen in children with spastic cerebral palsy: a double-blind, randomized, placebo-controlled, dose-finding study. Dev Med Child Neurol. 2007;49(9):654–9.

    Article  PubMed  Google Scholar 

  21. Horn TS, Yablon SA, Stokic DS. Effect of intrathecal baclofen bolus injection on temporospatial gait characteristics in patients with acquired brain injury. Arch Phys Med Rehabil. 2005;86(6):1127–33.

    Article  PubMed  Google Scholar 

  22. Stokic DS, Yablon SA, Hayes A. Comparison of clinical and neurophysiologic responses to intrathecal baclofen bolus administration in moderate-to-severe spasticity after acquired brain injury. Arch Phys Med Rehabil. 2005;86(9):1801–6.

    Article  PubMed  Google Scholar 

  23. Baguley IJ, Bailey KM, Slewa-Younan S. Prolonged anti-spasticity effects of bolus intrathecal baclofen. Brain Inj. 2005;19(7):545–8.

    Article  CAS  PubMed  Google Scholar 

  24. Narouze S, Benzon HT, Provenzano DA, Buvanendran A, De Andres J, Deer TR, et al. Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications: guidelines from the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain. Reg Anesth Pain Med. 2015;40(3):182–212.

    Article  CAS  PubMed  Google Scholar 

  25. Snider KT, Kribs JW, Snider EJ, Degenhardt BF, Bukowski A, Johnson JC. Reliability of Tuffier’s line as an anatomic landmark. Spine (Phila Pa 1976). 2008;33(6):E161–5.

    Article  Google Scholar 

  26. Pierce DB, Shivaram G, Koo KSH, Shaw DWW, Meyer KF, Monroe EJ. Ultrasound-guided lumbar puncture in pediatric patients: technical success and safety. Pediatr Radiol. 2018;48(6):875–81.

    Article  PubMed  Google Scholar 

  27. Saulino M, Anderson DJ, Doble J, Farid R, Gul F, Konrad P, et al. Best practices for intrathecal baclofen therapy: troubleshooting. Neuromodulation. 2016;19(6):632–41.

    Article  PubMed  Google Scholar 

  28. Weaver JJ, Natarajan N, Shaw DWW, Apkon SD, Koo KSH, Shivaram GM, et al. Transforaminal intrathecal delivery of nusinersen using cone-beam computed tomography for children with spinal muscular atrophy and extensive surgical instrumentation: early results of technical success and safety. Pediatr Radiol. 2018;48(3):392–7.

    Article  PubMed  Google Scholar 

  29. Brook AD, Burns J, Dauer E, Schoendfeld AH, Miller TS. Comparison of CT and fluoroscopic guidance for lumbar puncture in an obese population with prior failed unguided attempt. J Neurointerv Surg. 2014;6(4):324–8.

    Article  PubMed  Google Scholar 

  30. Phillips MM, Miljkovic N, Ramos-Lamboy M, Moossy JJ, Horton J, Buhari AM, et al. Clinical experience with continuous intrathecal baclofen trials prior to pump implantation. PM R. 2015;7(10):1052–8.

    Article  PubMed  Google Scholar 

  31. Staats PS. Complications of intrathecal therapy. Pain Med. 2008;9(S1):S102–7.

    Article  Google Scholar 

  32. Yablon SA, Stokic DS. Neurophysiologic evaluation of spastic hypertonia: implications for management of the patient with the intrathecal baclofen pump. Am J Phys Med Rehabil. 2004;83(10 Suppl):S10–8.

    Article  PubMed  Google Scholar 

  33. Gwartz BL. Intrathecal baclofen for spasticity caused by thrombotic stroke. Am J Phys Med Rehabil. 2001;80(5):383–7.

    Article  CAS  PubMed  Google Scholar 

  34. Ahmed SV, Jayawarna C, Jude E. Post lumbar puncture headache: diagnosis and management. Postgrad Med J. 2006;82(973):713–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Riley CA, Spiegel JE. Complications following large-volume epidural blood patches for postdural puncture headache. Lumbar subdural hematoma and arachnoiditis: initial cause or final effect? J Clin Anesth. 2009;21(5):355–9.

    Article  PubMed  Google Scholar 

  36. Kent S, Mehaffey G. Transnasal sphenopalatine ganglion block for the treatment of postdural puncture headache in obstetric patients. J Clin Anesth. 2016;34:194–6.

    Article  CAS  PubMed  Google Scholar 

  37. Boster AL, Bennett SE, Bilsky GS, Gudesblatt M, Koelbel SF, McManus M, et al. Best practices for intrathecal baclofen therapy: screening test. Neuromodulation. 2016;19(6):616–22.

    Article  PubMed  Google Scholar 

  38. Kopell BH, Sala D, Doyle WK, Feldman DS, Wisoff JH, Weiner HL. Subfascial implantation of intrathecal baclofen pumps in children: technical note. Neurosurgery. 2001;49(3):753–6; discussion 756–7.

    CAS  PubMed  Google Scholar 

  39. Motta F, Stignani C, Antonello CE. Upper limb function after intrathecal baclofen treatment in children with cerebral palsy. J Pediatr Orthop. 2008;28(1):91–6.

    Article  PubMed  Google Scholar 

  40. Penn RD. Intrathecal medication delivery. Neurosurg Clin N Am. 2003;14(3):381–7.

    Article  PubMed  Google Scholar 

  41. Heetla HW, Staal MJ, van Laar T. Tolerance to continuous intrathecal baclofen infusion can be reversed by pulsatile bolus infusion. Spinal Cord. 2010;48(6):483–6.

    Article  CAS  PubMed  Google Scholar 

  42. Heetla HW, Staal MJ, Kliphuis C, van Laar T. The incidence and management of tolerance in intrathecal baclofen therapy. Spinal Cord. 2009;47(10):751–6.

    Article  CAS  PubMed  Google Scholar 

  43. Ilias W, le Polain B, Buchser E, Demartini L, oPTiMa study group. Patient-controlled analgesia in chronic pain patients: experience with a new device designed to be used with implanted programmable pumps. Pain Pract. 2008;8(3):164–70.

    Article  PubMed  Google Scholar 

  44. Flack SH, Bernards CM. Cerebrospinal fluid and spinal cord distribution of hyperbaric bupivacaine and baclofen during slow intrathecal infusion in pigs. Anesthesiology. 2010;112(1):165–73.

    Article  CAS  PubMed  Google Scholar 

  45. Heetla HW, Proost JH, Molmans BH, Staal MJ, van Laar T. A pharmacokinetic-pharmacodynamic model for intrathecal baclofen in patients with severe spasticity. Br J Clin Pharmacol. 2016;81(1):101–12.

    Article  CAS  PubMed  Google Scholar 

  46. Kofler M, Matzak H, Saltuari L. The impact of intrathecal baclofen on gastrointestinal function. Brain Inj. 2002;16(9):825–36.

    Article  PubMed  Google Scholar 

  47. Morant A, Noe E, Boyer J, Escamilla B, Trenor C, Ferri J, et al. Paralytic ileus: a complication after intrathecal baclofen therapy. Brain Inj. 2006;20(13–14):1451–4.

    Article  PubMed  Google Scholar 

  48. Vaidyanathan S, Soni BM, Oo T, Hughes PL, Singh G, Watt JW, et al. Bladder stones – red herring for resurgence of spasticity in a spinal cord injury patient with implantation of Medtronic Synchromed pump for intrathecal delivery of baclofen – a case report. BMC Urol. 2003;3:3.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Carda S, Cazzaniga M, Taiana C, Pozzi R. Intrathecal baclofen bolus complicated by deep vein thrombosis and pulmonary embolism. A case report. Eur J Phys Rehabil Med. 2008;44(1):87–8.

    CAS  PubMed  Google Scholar 

  50. Murphy NA. Deep venous thrombosis as a result of hypotonia secondary to intrathecal baclofen therapy: a case report. Arch Phys Med Rehabil. 2002;83(9):1311–2.

    Article  PubMed  Google Scholar 

  51. Rigoli G, Terrini G, Cordioli Z. Intrathecal baclofen withdrawal syndrome caused by low residual volume in the pump reservoir: a report of 2 cases. Arch Phys Med Rehabil. 2004;85(12):2064–6.

    Article  PubMed  Google Scholar 

  52. Maneyapanda MB, Chang Chien GC, Mattie R, Amorapanth P, Reger C, McCormick ZL. Ultrasound guidance for technically challenging intrathecal baclofen pump refill: three cases and procedure description. Am J Phys Med Rehabil. 2016;95(9):692–7.

    Article  PubMed  Google Scholar 

  53. Miracle AC, Fox MA, Ayyangar RN, Vyas A, Mukherji SK, Quint DJ. Imaging evaluation of intrathecal baclofen pump-catheter systems. AJNR Am J Neuroradiol. 2011;32(7):1158–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Coyne PJ, Hansen LA, Laird J, Buster P, Smith TJ. Massive hydromorphone dose delivered subcutaneously instead of intrathecally: guidelines for prevention and management of opioid, local anesthetic, and clonidine overdose. J Pain Symptom Manag. 2004;28(3):273–6.

    Article  Google Scholar 

  55. Elovic E, Kirshblum SC. Managing spasticity in spinal cord injury: safe administration of bridge boluses during intrathecal baclofen pump refills. J Spinal Cord Med. 2003;26(1):2–4.

    Article  PubMed  Google Scholar 

  56. Coffey RJ, Edgar TS, Francisco GE, Graziani V, Meythaler JM, Ridgely PM, et al. Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome. Arch Phys Med Rehabil. 2002;83(6):735–41.

    Article  PubMed  Google Scholar 

  57. Hansen CR, Gooch JL, Such-Neibar T. Prolonged, severe intrathecal baclofen withdrawal syndrome: a case report. Arch Phys Med Rehabil. 2007;88(11):1468–71.

    Article  PubMed  Google Scholar 

  58. Agarwal SK, Kriel RL, Cloyd JC, Coles LD, Scherkenbach LA, Tobin MH, et al. A pilot study assessing pharmacokinetics and tolerability of oral and intravenous baclofen in healthy adult volunteers. J Child Neurol. 2015;30(1):37–41.

    Article  PubMed  Google Scholar 

  59. Dalton C, Keenan E, Stevenson V. A novel cause of intrathecal baclofen overdosage: lessons to be learnt. Clin Rehabil. 2008;22(2):188–90.

    Article  PubMed  Google Scholar 

  60. Lew SM, Psaty EL, Abbott R. An unusual cause of overdose after baclofen pump implantation: case report. Neurosurgery. 2005;56(3):E624; discussion E624.

    Article  PubMed  Google Scholar 

  61. Sauter K, Kaufman HH, Bloomfield SM, Cline S, Banks D. Treatment of high-dose intrathecal morphine overdose. Case report. J Neurosurg. 1994;81(1):143–6.

    Article  CAS  PubMed  Google Scholar 

  62. Sgouros S, Charalambides C, Matsota P, Tsangaris I, Kostopanagiotou G. Malfunction of SynchroMed II baclofen pump delivers a near-lethal baclofen overdose. Pediatr Neurosurg. 2010;46(1):62–5.

    Article  CAS  PubMed  Google Scholar 

  63. Albright AL, Thompson K, Carlos S, Minnigh MB. Cerebrospinal fluid baclofen concentrations in patients undergoing continuous intrathecal baclofen therapy. Dev Med Child Neurol. 2007;49(6):423–5.

    Article  PubMed  Google Scholar 

  64. Shirley KW, Kothare S, Piatt JH Jr, Adirim TA. Intrathecal baclofen overdose and withdrawal. Pediatr Emerg Care. 2006;22(4):258–61.

    Article  PubMed  Google Scholar 

  65. Penn RD, Savoy SM, Corcos D, Latash M, Gottlieb G, Parke B, et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med. 1989;320(23):1517–21.

    Article  CAS  PubMed  Google Scholar 

  66. Bethoux F, Boulis N, McClelland S 3rd, Willis MA, Hussain M, Machado A, et al. Use of intrathecal baclofen for treatment of severe spasticity in selected patients with motor neuron disease. Neurorehabil Neural Repair. 2013;27(9):828–33.

    Article  PubMed  Google Scholar 

  67. Erwin A, Gudesblatt M, Bethoux F, Bennett SE, Koelbel S, Plunkett R, et al. Intrathecal baclofen in multiple sclerosis: too little, too late? Mult Scler. 2011;17(5):623–9.

    Article  PubMed  Google Scholar 

  68. Vaidyanathan S, Soni BM, Oo T, Hughes PL, Singh G, Mansour P. Delayed complications of discontinuation of intrathecal baclofen therapy: resurgence of dyssynergic voiding, which triggered off autonomic dysreflexia and hydronephrosis. Spinal Cord. 2004;42(10):598–602.

    Article  CAS  PubMed  Google Scholar 

  69. Kosturakis A, Gebhardt R. SynchroMed II intrathecal pump memory errors due to repeated magnetic resonance imaging. Pain Physician. 2012;15(6):475–7.

    PubMed  Google Scholar 

  70. Maino P, Koetsier E, Perez RS. Fentanyl overdose caused by malfunction of SynchroMed II intrathecal pump: two case reports. Reg Anesth Pain Med. 2014;39(5):434–7.

    Article  PubMed  Google Scholar 

  71. Wesemann K, Coffey RJ, Wallace MS, Tan Y, Broste S, Buvanendran A. Clinical accuracy and safety using the SynchroMed II intrathecal drug infusion pump. Reg Anesth Pain Med. 2014;39(4):341–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Pasquier Y, Cahana A, Schnider A. Subdural catheter migration may lead to baclofen pump dysfunction. Spinal Cord. 2003;41(12):700–2.

    Article  CAS  PubMed  Google Scholar 

  73. Sorokin A, Annabi E, Yang WC, Kaplan R. Subdural intrathecal catheter placement: experience with two cases. Pain Physician. 2008;11(5):677–80.

    Article  PubMed  Google Scholar 

  74. Stinchon JF, Shah NP, Ordia J, Oates E. Scintigraphic evaluation of intrathecal infusion systems: selection of patients for surgical or medical management. Clin Nucl Med. 2006;31(1):1–4.

    Article  CAS  PubMed  Google Scholar 

  75. Deer TR, Prager J, Levy R, Rathmell J, Buchser E, Burton A, et al. Polyanalgesic Consensus Conference--2012: consensus on diagnosis, detection, and treatment of catheter-tip granulomas (inflammatory masses). Neuromodulation. 2012;15(5):483–95; discussion 496.

    Article  PubMed  Google Scholar 

  76. Leibold AT, Weyhenmeyer J, Lee A. Simultaneous explantation and implantation of intrathecal pumps: a case series. J Neurosurg. 2020;132(5):1398–404.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael Saulino .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Saulino, M. (2022). Intrathecal Baclofen Therapy. In: Raghavan, P. (eds) Spasticity and Muscle Stiffness. Springer, Cham. https://doi.org/10.1007/978-3-030-96900-4_11

Download citation

Publish with us

Policies and ethics